Malu Gamez Tansey, Ph.D.

Media Releases

Get to know Neuroscientist Dr. Malú Gámez Tansey, who conducts neurological research in Gainesville, Florida.

Dr. Tansey, an esteemed American physiologist and neuroscientist, holds several significant roles, including having served as the Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida. She is also recognized as an Evelyn F. and William L. McKnight Brain Investigator and an Investigator at the Norman Fixel Institute for Neurological Diseases.

As the principal investigator of the Tansey Lab, Dr. Tansey guides a research program centered around investigating the role of neuroimmune interactions in the development and progression of neurodegenerative and neuropsychiatric disease. Her work is primarily focused on exploring the cellular and molecular basis of peripheral and central inflammation in the pathology of age-related neurodegenerative diseases like Alzheimer’s disease and amyotrophic lateral sclerosis. 

The Tansey Lab’s endeavors are concentrated on comprehending the intricate role of inflammation and immune system responses in brain health and the development of diseases. Dr. Tansey’s overarching objective is to contribute to the advancement of therapies that can effectively prevent or delay the onset of age-related neurodegenerative diseases. Through her multifaceted roles and groundbreaking basic and translational research, she remains at the forefront of efforts to enhance the understanding of these complex conditions and pave the way for improved therapeutic interventions in the clinic.

Born in El Paso, Texas, Dr. Tansey attended Loretto Academy high school and obtained her B.S/M.S in Biological Sciences from Stanford University. After graduating in 1985, she pursued her graduate studies in Physiology and Cell Cycle Regulation at the University of Texas Southwestern Medical Center. Under the mentorship of James T. Stull, she explored the role of myosin light chain kinase (MLCK) phosphorylation in the regulation of smooth muscle contraction.

Following the completion of her graduate studies in 1992, Dr. Tansey moved to Washington University in St. Louis, Missouri, where she worked under the mentorship of Eugene M. Johnson in the Department of Molecular Pharmacology.

After completing her postdoctoral work, she then moved to California to work in industry for a few years as the group leader of Chemical Genetics at Xencor Inc. in Monrovia. She co-invented novel soluble TNF inhibitors that have now advanced to clinical trials in Alzheimer’s disease. 

In 2009, Dr. Tansey moved to Emory University as tenured Professor of Physiology where she established the Center for Neurodysfunction and Inflammation. As a Hispanic American, she has served as a role model to numerous undergraduate, graduate and post-graduate trainees, many of them women from underrepresented minority groups. She served as co-director of Emory’s Initiative for Maximizing Student Development (IMSD). Their mission is to strengthen institutional efforts to enhance recruitment and retention of diverse student and faculty bodies at Emory, by providing research training and mentoring opportunities to both. Dr. Tansey is a fierce advocate for women and other under-represented groups in STEM and has earned several mentoring awards from students and faculty for her efforts in this area.

In 2019, Tansey was recruited to the University of Florida, where she continues to work to this day. In addition to her leadership roles at UF, she is on the Board of Directors for the World Parkinson’s Coalition, the Scientific Advisory Board for the Parkinson Foundation, and the Medical and Scientific Advisory Group for the Alzheimer’s Association. 

In her spare time, Dr. Tansey enjoys talking to patient and research-advocacy groups, cooking, sailing, and scuba-diving.

Recommended Articles

• Understanding Hallucinations and Brain Disconnections in Parkinson's Disease

  The ProblemThose who suffer from Parkinson’s may experience a variety of symptoms through their life, but doctors state that Parkinson's patients who experience hallucination are more susceptible to encountering disconnections in their brains relative to Parkinson's patients that are not...

• The Color Red Can Boost Your Energy

  According to a new study, seeing the color red may help to move the muscles faster and stronger with more force. This new finding may have applications in sports and other activities where a quick boost of energy is required.According to researcher Andrew Elliot, professor of psychology at the...

• Facts About Meningitis Vaccines

  IntroductionThe only way to prevent serious and life-threatening diseases such as meningitis is through vaccination. Meningitis can also be caused by viral, bacterial, and fungal infections. The infection usually affects the meninges or membranes that enclose the brain and spinal cord. Although...

• 15-State Bicycle Journey Helps Raise Money and Awareness for Muscular Dystrophy

  To raise awareness and funding for muscular dystrophy, a 4,200 mile bike ride was organized that started in Seattle, Washington and ended at the Barclays Center in Brooklyn, New York, with a total of 15 states being crossed by the end.  The event consisted of roughly 12 cyclists, and was made...

• Labyrinthitis and Vertigo

  Labyrinthitis is an inflammation of the inner ear due to a virus or bacteria. This inflammation of the inner ear disrupts the transmission of the sensory information to the brain. When it happens, symptoms similar to those of vertigo may be experienced as well as difficulties in vision and hearing....

• Antidepressants May Pose a Risk for Alzheimer's Patients

  Research shows that patients newly diagnosed with Alzheimer's disease who recently began using antidepressents are at a higher risk for head injuries and traumatic brain injuries. Heidi Taipale and colleagues from the University of Eastern Finland wrote that for older people who use...